business / news / / Benzinga
Estee Lauder Invests In 111SKIN.
Estee Lauder announced a minority investment in clinical skincare brand 111SKIN; terms remain undisclosed.
KEY POINTS
- 111SKIN derives 20% of its sales from direct-to-consumer channels and has a global luxury presence.
- Estee Lauder is trading 22% below its 100-day SMA, signaling continued intermediate-term weakness.
- Analyst price targets for Estee Lauder have recently been lowered, despite maintaining a Buy consensus.
- Estee Lauder has significant ETF exposure, influencing the stock during large ETF inflows or outflows.
COMPANIES
Summarized by Newsio from Benzinga. How we summarize →